Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation ...

Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

Advancements in heart transplant technology, focusing on machine perfusion's role in extending the time window for organ ...

One heart retrieval method exhibited lower risk during donation after circulatory death, according to results from an international, multicenter study shared at the International Society for Heart and ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

At today's Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month ...

27 April 2025, Boston—Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) marked the 10-year anniversary of modern ...

Boston—Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication regimens ...

For the first time, surgeons have successfully performed a remarkable new heart transplant in which the donor organ never ...